Recombinant Xanthomonas campestris pv. vesicatoria Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
mtgA; XCV3184; Biosynthetic peptidoglycan transglycosylase; Glycan polymerase; Peptidoglycan glycosyltransferase MtgA; PGT
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-248
Protein Length
full length protein
Species
Xanthomonas campestris pv. vesicatoria (strain 85-10)
Target Names
mtgA
Target Protein Sequence
MGMDAWDGKQAAPPRRARRWLRWLMAAPLLFAAASVLQVLILRVVDPPISSMMVGRYLEA WGEGDWRFSLHQQWRDYDKIAASLPILVVAAEDQQFPMHHGFDLQAIEKARDHNARGGRV RGASTISQQVAKNVFLWQGRSWVRKGLEAWYTVLIELFWPKQRILEMYLNVAEFGDGVYG AQAAAQQFWSKDAAGLSPSESARLAAVLPSPRRYDARRPGAFVQRRATWIQRQARQLGGP VYLQGPSR
Uniprot No.

Target Background

Function

Recombinant Xanthomonas campestris pv. vesicatoria Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA) is a peptidoglycan polymerase that catalyzes glycan chain elongation from lipid-linked precursors.

Database Links

KEGG: xcv:XCV3184

STRING: 316273.XCV3184

Protein Families
Glycosyltransferase 51 family
Subcellular Location
Cell inner membrane; Single-pass membrane protein.

Q&A

What is the basic structure and function of mtgA in Xanthomonas campestris?

Monofunctional biosynthetic peptidoglycan transglycosylase (mtgA) in Xanthomonas campestris is a critical enzyme involved in bacterial cell wall synthesis. The mature protein consists of 246 amino acids with a molecular structure that includes a catalytic domain responsible for glycan chain polymerization during peptidoglycan synthesis . The protein contains a characteristic N-terminal transmembrane domain followed by an extracellular catalytic domain, which is typical of peptidoglycan synthases. The full amino acid sequence reveals several conserved motifs essential for its enzymatic function: MGTDGLDDKQARPPRRARRSLRWVLAAPLLFAAASVLQVLALRIIDPPISTVMVGRYLEA WGEGEAGFSLHHQWRDLDEIAPSLPISVVAAEDQQFPSHHGFDLQAIEKARDYNARGGRV RGASTISQQVAKNVFLWQGRSWVRKGLEAWYTLLIELFWPKQRILEMYVNVAEFGDGIYG AQAAARQFWGKDASRLTPTESARLAAVLPSPRRYDARRPGAYVQRRTAWIQRQARQLGGP GYLQAP .

Functionally, mtgA catalyzes the polymerization of lipid II precursors to form the glycan strands of peptidoglycan, acting as a transglycosylase that forms β-1,4 glycosidic bonds between N-acetylmuramic acid and N-acetylglucosamine residues. Unlike bifunctional penicillin-binding proteins (PBPs), mtgA lacks transpeptidase activity and works in concert with other enzymes to complete cell wall synthesis. Its role is particularly important during bacterial growth and division phases.

How does mtgA differ between Xanthomonas campestris pathovars?

Different pathovars of Xanthomonas campestris, including pv. campestris and pv. vesicatoria, show variations in their mtgA proteins that reflect their adaptation to different host plants and infection strategies. While the core catalytic domain remains highly conserved, subtle differences in amino acid sequences may affect substrate specificity, enzyme activity, or regulation mechanisms. Comparative genomic studies have revealed that pathovar-specific variations often occur in non-catalytic regions of the protein that may influence interaction with other cell wall synthesis enzymes or regulatory proteins .

These differences can be critical when designing experiments, as findings from one pathovar may not directly translate to another. For instance, expression patterns of cell wall synthesis genes in X. campestris pv. campestris have been shown to vary according to growth stage and environmental conditions, with implications for pathogenicity . When studying X. campestris pv. vesicatoria mtgA, researchers should acknowledge these potential pathovar-specific characteristics and avoid direct extrapolation of all findings from pv. campestris studies.

What expression systems are most effective for producing recombinant mtgA?

For successful expression of recombinant mtgA from Xanthomonas campestris, Escherichia coli-based expression systems have proven highly effective, particularly for laboratory-scale research purposes . The most commonly used approach involves:

  • Cloning the mtgA gene into an expression vector with an N-terminal His-tag for purification

  • Transforming the construct into an E. coli expression strain (commonly BL21(DE3) or derivatives)

  • Inducing expression under controlled conditions (temperature, IPTG concentration, duration)

  • Optimizing growth media and conditions for maximum protein yield

This approach has been successfully employed to produce full-length mtgA protein (1-246 amino acids) with an N-terminal His-tag, allowing for efficient purification using nickel affinity chromatography . The recombinant protein typically requires storage in Tris/PBS-based buffer with 6% trehalose at pH 8.0 to maintain stability, and addition of 5-50% glycerol is recommended for long-term storage at -20°C/-80°C .

Expression System ComponentOptimized Condition
Expression VectorpET series with N-terminal His-tag
E. coli StrainBL21(DE3) or Rosetta™
Induction Temperature18-25°C (reduced temperature improves folding)
IPTG Concentration0.1-0.5 mM
Induction Duration12-16 hours
Growth MediaLB or TB supplemented with glucose
Storage BufferTris/PBS with 6% trehalose, pH 8.0
Long-term Storage50% glycerol at -80°C

How can experimental design optimize the study of mtgA enzyme kinetics?

Designing rigorous experiments to study mtgA enzyme kinetics requires careful consideration of multiple factors. A well-structured experimental approach should follow these principles:

First, establish precise control over the testing environment to eliminate confounding variables . This includes maintaining consistent temperature, pH, and ionic strength conditions throughout experiments. Second, develop sound experimental treatments with clearly defined independent variables (e.g., substrate concentration, enzyme concentration, potential inhibitors) . Third, ensure proper replication and randomization in experimental design to minimize bias and increase statistical power .

For specific mtgA kinetic studies, researchers should:

  • Use purified enzyme with >90% purity as determined by SDS-PAGE to ensure reliable kinetic measurements

  • Employ synthetic lipid II analogs as substrates at varying concentrations to determine Km and Vmax parameters

  • Utilize multiple analytical methods (e.g., HPLC, mass spectrometry) to quantify reaction products

  • Include appropriate controls for substrate spontaneous hydrolysis and enzyme stability

  • Monitor reaction progress in real-time when possible using fluorescence-based assays

Comparing kinetic parameters across different experimental conditions requires statistical analysis to determine significant differences. For temperature-dependent studies, Arrhenius plots can identify activation energies and temperature optima. For inhibitor studies, various inhibition models (competitive, non-competitive, uncompetitive) should be tested to determine the most appropriate fit to the data.

What role does mtgA play in bacterial pathogenicity and host-pathogen interactions?

The role of mtgA in pathogenicity can be investigated through targeted approaches similar to those used for studying other virulence factors in Xanthomonas species. Evidence from related research suggests that peptidoglycan synthesis enzymes like mtgA contribute significantly to bacterial fitness during infection. Studies of superoxide dismutase (SOD) genes in X. campestris pv. campestris have shown that expression of certain genes essential for bacterial survival is induced within 3-4 hours after plant inoculation, with similar kinetics during both compatible and incompatible interactions .

For mtgA specifically, researchers should design experiments that:

  • Generate conditional knockdown mutants (since complete knockout may be lethal, as observed with certain essential genes in X. campestris pv. campestris)

  • Create transcriptional fusions (such as mtgA-gus) to monitor gene expression during different infection stages

  • Perform in planta studies comparing compatible and incompatible plant interactions

  • Analyze peptidoglycan structure in wild-type versus mutant strains

  • Test sensitivity to host defense molecules that target cell wall integrity

These approaches allow researchers to establish causal relationships between mtgA activity and pathogenicity. When conducting such studies, it's essential to include positive controls (known virulence factors) and negative controls (non-pathogenic mutants) to validate experimental findings.

How does the mtgA protein interact with other cell wall synthesis enzymes?

Understanding protein interactions in the multi-enzyme cell wall synthesis machinery requires sophisticated biochemical and genetic approaches. For mtgA specifically, researchers can employ:

  • Co-immunoprecipitation studies: Using antibodies against tagged mtgA to pull down interaction partners, followed by mass spectrometry identification

  • Bacterial two-hybrid assays: Testing direct protein-protein interactions between mtgA and candidate partners

  • Fluorescence resonance energy transfer (FRET): Visualizing protein interactions in live cells using fluorescently tagged proteins

  • Synthetic lethality screens: Identifying genes that become essential in mtgA-deficient backgrounds

Experimental evidence from related systems suggests that monofunctional transglycosylases like mtgA likely interact with:

  • Penicillin-binding proteins (PBPs) with transpeptidase activity

  • Cell division proteins (e.g., FtsZ, FtsW)

  • Peptidoglycan hydrolases involved in cell wall remodeling

  • Regulatory proteins that coordinate cell wall synthesis with growth

These interactions can be mapped onto structural models of the cell wall synthesis machinery to develop a comprehensive understanding of how mtgA functions within this complex.

What are the optimal purification methods for maintaining mtgA enzymatic activity?

Maintaining enzymatic activity during purification is crucial for obtaining functional mtgA protein for biochemical studies. Based on successful purification protocols for recombinant mtgA from X. campestris pv. campestris, the following methodology is recommended:

  • Initial extraction: Use gentle lysis methods (e.g., lysozyme treatment followed by sonication) in buffers containing protease inhibitors to prevent degradation

  • Primary purification: Employ nickel affinity chromatography for His-tagged protein using imidazole gradients for elution

  • Secondary purification: Apply size exclusion chromatography to separate aggregates and ensure homogeneity

  • Buffer optimization: Maintain protein in Tris/PBS-based buffer with 6% trehalose at pH 8.0 to preserve structure and function

  • Storage considerations: Add glycerol (5-50%, with 50% being optimal) for long-term storage at -20°C/-80°C

  • Avoid repeated freeze-thaw cycles: Aliquot purified protein and limit working stocks to 4°C for up to one week

Activity assays should be performed at each purification step to track recovery of enzymatic function. The final purified protein should achieve >90% purity as determined by SDS-PAGE . For particularly sensitive applications, additional chromatography steps (e.g., ion exchange) may be necessary to remove minor contaminants.

How can researchers troubleshoot expression and purification challenges with mtgA?

Researchers often encounter challenges when working with membrane-associated enzymes like mtgA. The following troubleshooting strategies address common issues:

ChallengePotential CausesTroubleshooting Strategies
Low expression yieldToxicity to host cells, codon bias, inefficient transcription/translation- Optimize codon usage for E. coli
- Use lower induction temperature (16-18°C)
- Test different E. coli strains (e.g., C41/C43 for toxic proteins)
- Reduce inducer concentration
Protein insolubilityImproper folding, membrane association, inclusion body formation- Include mild detergents in lysis buffer
- Test fusion partners (e.g., MBP, SUMO)
- Optimize lysis conditions
- Consider refolding protocols from inclusion bodies
Loss of activity during purificationOxidation, proteolysis, cofactor loss, improper buffer conditions- Add reducing agents (e.g., DTT, β-mercaptoethanol)
- Include protease inhibitors
- Maintain appropriate pH and ionic strength
- Add stabilizing agents (e.g., glycerol, trehalose)
Protein aggregationImproper folding, concentration too high, buffer incompatibility- Optimize buffer composition
- Add stabilizing agents
- Determine optimal protein concentration
- Filter solutions before concentration

When all standard approaches fail, researchers should consider:

  • Expressing truncated versions of the protein (removing transmembrane domains)

  • Using cell-free expression systems

  • Switching to alternative expression hosts (e.g., yeast, insect cells)

  • Co-expressing with chaperone proteins to aid folding

What analytical methods are most effective for characterizing mtgA enzymatic activity?

Comprehensive characterization of mtgA enzymatic activity requires multiple complementary analytical approaches:

  • Spectrophotometric assays: Continuous monitoring of substrate utilization or product formation using coupled enzyme systems that generate chromogenic or fluorogenic products

  • HPLC analysis: Quantification of substrates and products to determine reaction kinetics and specificity

  • Mass spectrometry: Structural characterization of reaction products to confirm glycosyltransferase activity and identify novel products

  • Muropeptide analysis: Digestion of peptidoglycan products with muramidases followed by HPLC or LC-MS analysis to determine structural features

  • Radioactive assays: Using radiolabeled substrates (e.g., UDP-[14C]GlcNAc) to track product formation with high sensitivity

For advanced structure-function studies, researchers should combine these activity assays with:

  • Site-directed mutagenesis of conserved residues

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to identify substrate binding regions

  • X-ray crystallography or cryo-EM to determine three-dimensional structure

A typical experimental workflow would involve initial screening using simpler spectrophotometric methods, followed by more detailed characterization using HPLC and mass spectrometry for promising enzyme variants or conditions.

How should researchers analyze and interpret contradictory data regarding mtgA function?

When faced with contradictory data regarding mtgA function or activity, researchers should follow a systematic approach to resolve inconsistencies:

  • Verify experimental conditions: Minor differences in buffer composition, pH, temperature, or enzyme preparation can significantly affect results. Document and standardize all conditions across experiments .

  • Examine statistical robustness: Ensure adequate sample sizes and appropriate statistical tests. Perform power analyses to determine if experiments are sufficiently powered to detect real effects .

  • Consider biological variability: Biological systems exhibit inherent variability. Determine if contradictions reflect genuine biological phenomena rather than technical artifacts.

  • Implement multiple methodologies: Approach the same question using different techniques. Agreement across methodologies strengthens confidence in results.

  • Conduct blind experiments: Remove potential experimenter bias by blinding researchers to sample identity or expected outcomes when possible .

When analyzing contradictory findings in the literature regarding mtgA from different Xanthomonas pathovars, researchers should:

  • Compare experimental conditions and methodologies used in different studies

  • Consider genetic differences between bacterial strains

  • Evaluate differences in protein constructs (full-length vs. truncated, tag position)

  • Assess whether differences in host plant interactions might explain varying results

Publication bias toward positive results means contradictory findings may be underreported. Researchers should maintain thorough laboratory records of both confirmatory and contradictory results to facilitate accurate interpretation of the complete dataset.

What statistical approaches are most appropriate for analyzing mtgA enzymatic activity data?

Selecting appropriate statistical approaches for enzymatic data depends on the experimental design and specific questions being addressed. For mtgA activity studies, researchers should consider:

  • Enzyme kinetics modeling:

    • Non-linear regression for Michaelis-Menten kinetics to determine Km and Vmax parameters

    • Lineweaver-Burk, Eadie-Hofstee, or Hanes-Woolf transformations for alternative visualization

    • Global fitting approaches for inhibitor studies to distinguish between competitive, non-competitive, and uncompetitive mechanisms

  • Comparative studies:

    • ANOVA with post-hoc tests for comparing activity across multiple conditions

    • t-tests (paired or unpaired) for direct comparisons between two conditions

    • Non-parametric alternatives (Mann-Whitney U, Kruskal-Wallis) when normality assumptions are violated

  • Time-course experiments:

    • Repeated measures ANOVA or mixed-effects models for time-dependent changes

    • Curve-fitting approaches to determine reaction rates at different time points

  • Structure-function relationships:

    • Multiple regression or ANCOVA to relate structural parameters to activity measurements

    • Principal component analysis to identify patterns in complex datasets with multiple variables

For all statistical analyses, researchers should:

  • Clearly state null and alternative hypotheses

  • Establish significance criteria before data collection

  • Report effect sizes alongside p-values

  • Validate that data meet assumptions of selected statistical tests

  • Consider corrections for multiple comparisons when appropriate

Advanced statistical approaches like Bayesian methods can be particularly valuable when integrating prior knowledge with new experimental data on mtgA function.

What are the most promising future research directions for mtgA studies?

The study of mtgA in Xanthomonas campestris offers several promising research avenues that could significantly advance our understanding of bacterial cell wall synthesis and pathogenicity. Key future directions include:

  • Structural biology approaches: Solving the three-dimensional structure of mtgA would provide invaluable insights into its catalytic mechanism and facilitate structure-based inhibitor design. Cryo-EM and X-ray crystallography techniques continue to improve, making previously challenging membrane-associated proteins more accessible to structural analysis.

  • Systems biology integration: Investigating how mtgA functions within the broader network of cell wall synthesis machinery could reveal important regulatory connections. Global approaches like transcriptomics, proteomics, and metabolomics can help identify condition-specific regulation patterns similar to those observed for other essential genes in Xanthomonas .

  • Host-pathogen interaction studies: Exploring the specific role of mtgA in plant infection processes may reveal new aspects of bacterial virulence. In planta expression studies using transcriptional fusions have proven valuable for other Xanthomonas genes and could be applied to mtgA .

  • Comparative studies across pathovars: Systematically comparing mtgA structure, function, and regulation across different Xanthomonas pathovars could reveal adaptations specific to different host plant interactions.

  • Inhibitor development: As an essential enzyme for bacterial viability, mtgA represents a potential target for new antimicrobial compounds. High-throughput screening approaches combined with rational design based on structural information could yield valuable tool compounds for both research and potential therapeutic applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.